Loading...
SeaStar Medical Holding Corporation
ICU•NASDAQ
Healthcare
Biotechnology
$0.43
$0.00(0.00%)
SeaStar Medical Holding Corporation (ICU) Financial Performance & Statements
Review SeaStar Medical Holding Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-25.56%
↓ 25.56%
Net Income Growth
5.34%
↑ 5.34%
Operating Cash Flow Growth
-55.63%
↓ 55.63%
Operating Margin
-4138.79%
↓ 4138.79%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-3716.12%
↓ 3716.12%
ROE
601.84%
↑ 601.84%
ROIC
-3135.22%
↓ 3135.22%
SeaStar Medical Holding Corporation (ICU) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for SeaStar Medical Holding Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $67000.00 | $68000.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $67000.00 | $68000.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $0.00 | $0.00 |
| R&D Expenses | $2.74M | $2.34M | $2.33M | $1.70M |
| SG&A Expenses | $2.10M | $2.19M | $2.33M | $2.25M |
| Operating Expenses | $4.83M | $4.52M | $4.67M | $3.95M |
| Total Costs & Expenses | $4.83M | $4.52M | $4.67M | $3.95M |
| Interest Income | $19000.00 | $58000.00 | $25000.00 | $0.00 |
| Interest Expense | -$253000.00 | $272000.00 | $82000.00 | $143000.00 |
| Depreciation & Amortization | -$253000.00 | $250000.00 | $1.52M | $3.95M |
| EBITDA | -$4.67M | -$4.21M | -$3.15M | -$12.55M |
| EBITDA Ratio | -$69.73 | -$61.85 | ||
| Operating Income | -$4.77M | -$4.46M | -$4.67M | -$3.95M |
| Operating Income Ratio | -$71.15 | -$65.53 | ||
| Other Income/Expenses (Net) | $348000.00 | -$22000.00 | $1.44M | -$8.75M |
| Income Before Tax | -$4.42M | -$4.48M | -$3.23M | -$12.70M |
| Income Before Tax Ratio | -$65.96 | -$65.85 | ||
| Income Tax Expense | $0.00 | $0.00 | $3000.00 | -$3.95M |
| Net Income | -$4.42M | -$4.48M | -$3.24M | -$12.70M |
| Net Income Ratio | -$65.96 | -$65.85 | ||
| EPS | -$0.90 | -$1.10 | -$1.03 | -$4.73 |
| Diluted EPS | -$0.90 | -$1.10 | -$1.03 | -$4.73 |
| Weighted Avg Shares Outstanding | $5.98M | $4.09M | $3.15M | $2.68M |
| Weighted Avg Shares Outstanding (Diluted) | $5.98M | $4.09M | $3.15M | $2.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan